Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2001-08-21
2004-05-11
McKelvey, Terry (Department: 1636)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S029000, C435S325000, C435S348000, C435S366000
Reexamination Certificate
active
06733971
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to the field of regulation of gene expression, and more specifically to the modulation of transcription factors and genes in the hedgehog-mediated signaling pathway.
2. Description of the Related Art
Embryologists have long performed experimental manipulations that reveal the striking abilities of certain structures in vertebrate embryos to impose pattern upon surrounding tissues. Speculation on the mechanisms underlying these patterning effects usually centers on the secretion of a signaling molecule that elicits an appropriate response from the tissues being patterned. More recent work aimed at the identification of such signaling molecules implicates secreted proteins encoded by individual members of a small number of gene families. One such family of proteins which may have an influential effect upon patterning activities are those proteins encoded by the hedgehog gene family.
The hedgehog (hh) gene was initially identified based on its requirement for normal segmental patterning in Drosophila (N_sslein-Volhard, C. & Wieschaus, E,
Nature
287:795-801, 1980). Its functions include local signaling to coordinate the identities of adjacent cells within early embryonic segments (Hooper, J. E., & Scott, M. P.
Early Embryonic Development of Animals, pp.
1-48, 1992) and a later function in cuticle patterning that extends across many cell diameters (Heemskerk, J. & DiNardo, S.,
Cell,
76:449-460, 1994). The hh gene also functions in the patterning of imaginal precursors of adult structures, including the appendages and the eye (Mohler,
J. Genetics,
120:1061-1072, 1988; Ma, et al.,
Cell,
75:927-938, 1993; Heberlein, et al.,
Cell,
75:913-926, 1993; Tabata, T. & Kornberg, T. D.,
Cell,
76:89-102, 1992; Basler, K. & Struhl, G.,
Nature,
368:208-214, 1994). Genetic and molecular evidence indicates that hedgehog proteins are secreted and function in extracellular signaling (Mohler, J., supra; Lee, et al.,
Cell,
71:33-50, 1992; Taylor, et al.,
Mech. Dev.,
42:89-96, 1993).
In vertebrates, activities encoded by hh homologues have been implicated in anterior/posterior patterning of the limb (Riddle, et al.,
Cell,
75:1401-1416, 1993; Chang, et al.,
Development,
120:3339, 1994), and in dorsal/ventral patterning of the neural tube (Echelard, et al.,
Cell,
75:1417-1430, 1993; Krauss, et al.,
Cell,
75:1431-1444, 1993; Roelink, et al.,
Cell,
76:761-775, 1994).
In most of the embryonic tissues where Hedgehog signaling exerts a patterning effect, activation of the Hedgehog pathway is associated with a proliferative response in target cells. Such embryonic tissues include but are not limited to the developing neural tube, the presomitic mesoderm and the mesoderm of the developing limb bud. In addition, uncontrolled cell proliferation due to inappropriate activation of the Hedgehog signaling pathway is associated with formation of several tumor types including but not limited to basal cell carcinoma, medulloblastoma, and probably breast cancer and glioma. The uncontrolled proliferation in these tumors is probably due to the abnormal activation of transcription factors such as Gli1 that have a normal role in the Hedgehog signaling pathway. For example, in the case of basal cell carcinoma, all or nearly all cases are associated with inappropriately high level expression of the Gli1 transcription factor in basal keratinocytes (Dahmane et al.,
Nature
1997, 389(6653):876-881). Such inappropriate activation of Gli1 is thought to play a causal role in uncontrolled cell proliferation associated with basal cell carcinoma. The ability to modulate activity of such transcription factors thus represents a possible therapeutic approach to several clinically significant cancers.
The hedgehog polypeptide (HH)is synthesized as a precursor that undergoes autoprocessing to generate an amino-terminal fragment (HH-N)and a carboxyterminus fragment (HH-C). Lee et al.
Science,
266:1528-37, 1994. HH-N contains all the signaling activities of HH, whereas HH-C is responsible for the autoprocessing and attaches a cholesterol molecule to the carboxy-terminal of HH-N to regulate its spatial distribution. (Porter, J. A., et. al.
Nature,
374:363-366, 1995. Porter, J. A., et. al.
Science,
274:255-259, 1996. Porter, J. A. et. al.
Cell,
86:21-34, 1996).
SUMMARY OF THE INVENTION
The present invention is based on the seminal discovery that the hedgehog signaling pathway is regulated via a phosphorylated transcription factor in the hedgehog-mediated signaling pathway that undergoes dephosphorylation resulting in HH-mediated activation of target genes. Dephosphorylation of this transcription factor leads to increased binding to a hedgehog response element that is operatively associated with a target gene. Dephosphorylation of the transcription factor is mediated by a phosphatase.
In one embodiment, the invention provides an isolated transcription factor involved in a hedgehog-mediated signaling pathway. The transcription factor, which includes a phosphorylation site, is dephosphorylated in response to the hedgehog mediated signaling pathway which allows it to bind to a hedgehog response element. Preferably, the hedgehog response element is a sonic hedgehog response element (ShhRE) on a promoter for example. The sonic hedgehog response element contains the nucleic acid sequence 5′-GTT CTA CAT AAT GCG CCG-3′ (SEQ ID NO: 1) and the complementary sequence, 5′-CGG CGC ATT ATG TAG AAC-3′ (SEQ ID NO: 2).
In another embodiment, the invention includes a method for modulating expression of a target gene by modulating the phosphorylation of a transcription factor that interacts with a hedgehog response element operatively associated with the target gene. Preferably, the target gene is involved in a hedgehog signaling pathway, such as patched (ptc), the putative Shh receptor.
The phosphorylation of the transcription factor is modulated by affecting the activity of a phosphatase. Preferably, the modulation is inhibition of phosphatase signaling. In other preferred embodiments, the modulation is stimulation. Preferably, the phosphatase is a PP2A phosphatase or a phosphatase which can be inhibited by a PP2A phosphatase inhibitor, including okadaic acid or calyculin A for example.
The hedgehog signaling pathway may be any species of hedgehog, including the Drosophila, Zebrafish, Xenopus, chicken, murine or human hedgehog signaling pathway. In a preferred embodiment, the hedgehog signaling pathway is a vertebrate hedgehog signaling pathway, and more specifically, a human hedgehog signaling pathway.
The transcription factor of the invention may be a member of the Ci/Gli transcription factor family such as Cubitus interruptus (Ci) or Gli, or may be an unrelated transcription factor. The hedgehog response element may be a Ci-response element, a Gli-response element, or a sonic hedgehog response element for example.
In yet another embodiment, the present invention includes a method for treating a cell proliferative disorder in a subject. Examples of disorders that are likely targets for this type of treatment include but are not limited to basal cell carcinoma, medulloblastoma, and breast cancer, in all of which hedgehog pathway activation has been causally implicated. The method includes modulating hedgehog pathway activity by modulating activity of a phosphatase(s)that controls activity of transcription factors, such as Gli1.
In another embodiment, the invention includes a method for modulating proliferation or differentiation of neuronal cells. The method includes modulating phosphorylation of a transcription factor that binds to a hedgehog response element operatively associated with a target gene such as a gene that encodes a polypeptide that modulates proliferation or differentiation of the neuronal cells. For example, the target gene may encode COUP-TFII or a functional equivalent thereof.
The method may also include a step of detecting the proliferation or differentiation of the neuronal cells. Detecting inc
Beachy Philip A.
Chen Chien-Huan
Krishnan Venkatesh
Tsai Ming-Jer
Tsai Sophia
Baylor College of Medicine
Gray Cary Ware & Freidenrich LLP
Haile Lisa A.
McKelvey Terry
Vacchiano Emanuel J.
LandOfFree
Method for identifying an agent that affects a hedgehog... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for identifying an agent that affects a hedgehog..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying an agent that affects a hedgehog... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3225847